SLC2A2 (GLUT2) as a Novel Prognostic Factor for Hepatocellular Carcinoma

Oncotarget - United States
doi 10.18632/oncotarget.20266
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Identification of CELSR2 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

CTCs as a Prognostic Factor in Hepatocellular Carcinoma Patients and Liver Transplantation

HPB
HepatologyGastroenterology
2018English

SAC3D1: A Novel Prognostic Marker in Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2018English

CBX8 Exhibits Oncogenic Properties and Serves as a Prognostic Factor in Hepatocellular Carcinoma

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

The Systemic Inflammatory Response as a Prognostic Factor for Advanced Hepatocellular Carcinoma With Extrahepatic Metastasis

Molecular and Clinical Oncology
Cancer ResearchOncology
2016English

Updated Study on Action Mechanisms of Cereblon as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

HPB
HepatologyGastroenterology
2019English

The Role of Novel Prognostic Scores for Patients With Hepatocellular Carcinoma

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Prognostic Factors for Hepatocellular Carcinoma Recurrence

World Journal of Gastroenterology
MedicineGastroenterology
2014English

Glucose as a Prognostic Factor in Ovarian Carcinoma

Cancer
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy